Guideline-Recommended Treatments for HER2-Low Metastatic Breast Cancer

Treatment for HER2 low metastatic breast cancer may utilize HER2-targeted antibody-drug conjugates like T-DM1 and sacituzumab govitecan after initial therapy; knowing HER2 status, even low expression, is critical to guide use of these HER2-directed ADCs after chemotherapy.

Related Content:

Navigating HER2+ Metastatic Breast Cancer TreatmentBreast Cancer

Breast Cancer Survivor Advocates for Access to Scalp Cooling

Scalp Cooling Can Prevent Hair Loss During Chemo for Breast Cancer

Dealing With Peripheral Neuropathy After Breast Cancer Treatment